In accordance, TWIST1 KO in breast cancer cells inhibits the expression of epithelial to mesenchymal transition (EMT) markers, preventing metastases formation in immune-deficient mice (Li et al., 2014; Xu et al., 2017). Here, TWIST1 is linked to breast carcinoma.